NASDAQ:OGI Organigram Global Q4 2026 Earnings Date & Estimates $0.60 -0.03 (-4.76%) As of 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more. Organigram Global is estimated to report Q4 2026 earnings on Tuesday, December 15, 2026, before market opens. The conference call is scheduled for 9:30 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ4 2026Announcement DateDecember 15, 2026TimeBefore Market OpensConference Call9:30 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Organigram Global in Q4 2026Organigram Global is expected to post earnings of $0.02 per share on revenue of $84.67 million. In the same quarter a year earlier Organigram Global reported -$0.20 per share on revenue of $57.53 million. Organigram Global last reported on May 12, 2026, posting -$0.01 per share and matching the -$0.01 consensus estimate. Organigram Global has beaten the consensus EPS estimate in 1 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.02Expected Revenue$84.67 millionPrior-Year EPS-$0.20Prior-Year Revenue$57.53 millionExpected Revenue Growth+47.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.01 (Met Expectations)Last Quarter Revenue$42.99 millionEPS Beat Rate1 of last 8 quartersPrepare for the Q4 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Organigram Global Q4 2026 Earnings FAQ When does Organigram Global report Q4 2026 earnings? Organigram Global (NASDAQ:OGI) is estimated to report Q4 2026 earnings on Tuesday, December 15, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Organigram Global's Q4 2026 earnings call? Organigram Global's Q4 2026 earnings conference call is scheduled for Tuesday, December 15, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Organigram Global? Analysts expect Organigram Global to post earnings of $0.02 per share for Q4 2026. How much revenue is Organigram Global expected to report? The consensus revenue estimate for Organigram Global is $84.67 million for Q4 2026. Organigram Global Earnings HeadlinesOrganigram Global Gets Nasdaq Minimum Bid Price Requirement NotificationNovember 16, 2026 | marketscreener.comMOrganigram Provides NASDAQ Listing UpdateNovember 13, 2026 | businesswire.comBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's. A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all.November 20 at 1:00 AM | Banyan Hill Publishing (Ad)Organigram Global Confirms November 18 Record Date and December 23 Special MeetingNovember 10, 2026 | tipranks.comThe Big Winner From the Aurora Cannabis-Organigram Deal: CuraleafNovember 9, 2026 | fool.comTranscript : Organigram Global Inc. - Special CallSeptember 30, 2026 | marketscreener.comMSee More Organigram Global Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram Global and other key companies, straight to your email. Email Address About Organigram GlobalOrganigram Global (NASDAQ:OGI) is a Canadian cannabis company that cultivates, processes and sells cannabis and cannabinoid products. Its offerings include dried flower, pre-rolls, edibles, vape products, concentrates and cannabis-infused beverages, sold under brands such as Edison, SHRED, Big Bag O’ Buds and BOXHOT. The company traces its roots to Organigram, a licensed cannabis producer established in New Brunswick. It expanded its portfolio and manufacturing capabilities through acquisitions, including the 2024 purchase of Canadian cannabis company Motif Labs. Organigram primarily serves Canada’s adult-use cannabis market and also supplies medical cannabis and exports to select international markets. Its operations and products span multiple parts of the Canadian cannabis supply chain, from cultivation and processing to product development and distribution.View Organigram Global ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel ItAirfares Are Up, Flights Are Tight: 3 Airline Stocks Facing a Winter TestHard Drives Were Left for Dead, But Seagate and Western Digital Are SoaringPalo Alto Networks' Q1 Beat Gives Its Stock Rally Another Reason to RunGrand Theft Auto VI Arrives: Why Take-Two Is a Waiting GameWalmart Earnings Change the Narrative as Digital Growth Lifts OutlookWhatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It Upcoming Earnings Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026)Dell Technologies (11/24/2026)Deere & Company (11/25/2026)CrowdStrike (12/1/2026)Marvell Technology (12/1/2026)Bank Of Montreal (12/2/2026)Bank of Nova Scotia (12/2/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.